Unsere Webseite ist in Ihrer Darstellung an den aktuellen Stand verschiedener Web-Browser angepasst. Sollten Sie beim Aufruf unserer Webseite Fehler in der Darstellung feststellen, empfehlen wir Ihnen einen anderen Browser zu verwenden.
Tel.: +49 (0) 34901 - 885-7000

Everything from a single source

Internationally recognized:
Oncotec Pharma Produktion GmbH is a world-wide reliable partner for the manufacturing of aseptically produced cytostatics.
The special advantage:
Upon customer request, Oncotec offers a full range of services and is your contact point for the entire value-added chain: from the development via the market launch up to the regular commercial production.

Oncotec is part of the CDMO medac group.

Continuous customer growth:
Since the foundation in 1997, Oncotec has been able to continuously expand the production at the location of Dessau-Roßlau by dedicated customer support.
One reason for this: The production steps are executed on state-of-the-art production systems under isolator protection.

Pro Progress:
State of the art-process technology covers a cleanroom area of ca. 2,300 m²
The latest capacity extension became effective in 2010. Further steps have been followed. This means, among other things, the capacities for the production of ready-to-fill-syringes, freeze-drying, cycle-development as well as analytics shall be extended.

Under control:
Oncotec is regularly inspected by the State Administration Authorities of Saxony-Anhalt and has a valid Manufacturing Authorization as well as a GMP-Certificate. Beyond these legally required inspections, Oncotec meets regularly the controls and inspections through its customers.

A good investment:
Continuous investments in modernization and capacity expansion into, among other things, the areas of pre-filled syringe production, freeze-drying and laboratory ensure that Oncotec is well-equipped for the challenges of the future.

Inspections by Authorities:
ANVISA, the Japanese PMDA, US FDA and other foreign authorities

Pharma Produktion